| Similar Articles |
|---|
 |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India.   |
The Motley Fool
June 5, 2006
Stephen D. Simpson |
Reddy More Steady? Despite sharp sell-offs in India, Dr. Reddy's is still improving. As is often the case with turnarounds, the Indian pharmaceutical doesn't look especially cheap today. |
The Motley Fool
November 20, 2009
Jennifer Schonberger |
It's Time to Invest in India The outlook for investing in India ... plus a few stock ideas. |
The Motley Fool
March 24, 2004
Bill Mann |
Reddy or Not Dr. Reddy's is an Indian company with a booming business in pharmaceutical ingredient development and branded medications that it sells throughout the developing world. |
The Motley Fool
July 22, 2008
Brian Orelli |
The Growth Doctor Is In Dr. Reddy's grows the top line, but it still has some work to do. |
The Motley Fool
November 23, 2009
Jennifer Schonberger |
Here's Where to Invest in India The portfolio manager for T. Rowe Price's New Asia Fund gives some thoughts on investing in India. |
The Motley Fool
January 28, 2008
Brian Orelli |
Dr. Reddy's Rough Quarter Dr. Reddy's Laboratories moves manufacturing back to India and moves forward with OTC generic drugs. |
The Motley Fool
January 23, 2007
Brian Lawler |
No Generic Profit for Reddy Investors looking to hedge a pharmaceutical position in case of adverse congressional legislation (or those looking for an international company in booming India) might do well to look at Dr. Reddy's. |
The Motley Fool
February 18, 2009
Ivan Martchev |
3 Stock Ideas From an Emerging Powerhouse India's been hammered in the past year, but stocks are starting to look appealing again. Take a look at: Dr. Reddy's Laboratories... HDFC Bank... ICICI Bank... |
The Motley Fool
May 4, 2009
Ivan Martchev |
India Still Looks Strong Some very smart people are buying Indian equities right now. Here's why you should consider doing the same. |
BusinessWeek
February 27, 2006
Einhorn & Kripalani |
In India, Selling Generics Used To Be So Easy Suddenly, Indian drugmakers Dr. Reddy's and Ranbaxy have a host of copycat rivals. |
The Motley Fool
November 21, 2007
Adam J. Wiederman |
Black Friday Bargain Stock: Tata Motors Is Tata Motors a good value right now? Unlike it's poor-performing U.S. counterparts, India's largest automaker is far from frail, and offers greater growth potential than even Japanese automakers Honda and Toyota. |
The Motley Fool
May 1, 2008
Saibal Saha |
HDFC Bank Boasts Quantity and Quality India's HDFC Bank keeps blowing away its skeptics with successive years of high-octane, high-quality growth. |
The Motley Fool
May 21, 2007
Brian Orelli |
The Doctor Is on a Roller Coaster This quarter marks the end of the fiscal year for Dr. Reddy's, so investors should keep an eye out for the annual report. It should give a more complete picture of the road ahead. |
The Motley Fool
March 3, 2010
Jennifer Schonberger |
Great News for Investing in India The CEO of Kotak Mahindra New York has high praise for the Indian budget. More so than in any other country, the budget in India is the road map for the Indian economy. |
The Motley Fool
January 3, 2007
Will Frankenhoff |
Long-Term Investors Hitch a Ride With Tata Tata Motor's profits will be driven higher by demand from India's blossoming middle class. This is certainly not a stock in which I'd recommend investing your grandmother's nest egg, but for investors with a long-term horizon and an ability to stomach volatility, it might be worth taking a look. |
The Motley Fool
January 24, 2006
Stephen D. Simpson |
Reddy, Set, Go! After a tough stretch, leading Indian pharmaceutical company Dr. Reddy's may be ready to move again. This is still a turnaround story, though, so investors unable or unwilling to assume above-average risk should probably steer clear. |
The Motley Fool
May 21, 2008
Brian Orelli |
Dr. Reddy Needs an Amnesia Pill The pharmaceutical's year-over-year comparison headache is finally over. |
The Motley Fool
January 4, 2011
Nick Kapur |
India's Newest Motley Fool India's economy is growing at near double-digit rates. Its budding middle class is multiplying at incredible speeds. IPO markets are hot. And so this Motley Fool writer will be reporting directly from India. |
The Motley Fool
June 15, 2009
Brian Orelli |
Strange Bedfellows GlaxoSmithKline is teaming up with none other than its arch-nemesis, generic-drug maker Dr. Reddy's Laboratories, licensing more than 100 of their brands to sell in emerging markets. |
The Motley Fool
June 4, 2010
John Rosevear |
This Week in Autos Auto news: BYD's big move... Is India the next big auto market?... Coda's plans to hit the road... |
The Motley Fool
July 24, 2007
Brian Orelli |
A Generic Roller Coaster After being up last quarter, sales at Dr. Reddy's Laboratories plummet this quarter. Will they ride to another peak? |
The Motley Fool
January 19, 2012
John Rosevear |
Ford Finds Growth Around the World 2011 was a (mostly) strong year for the Blue Oval in key overseas markets. |
The Motley Fool
December 18, 2009
Jordan DiPietro |
Foreign Stocks You Can Actually Buy: India Finding foreign stocks on U.S. exchanges can be difficult, so here's a start. |
The Motley Fool
April 13, 2010
John Rosevear |
Ford's Plan for Global Domination The resurgent auto giant has a new source of growth. |
Chemistry World
July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
BusinessWeek
November 12, 2009
Srivastava & Rowley |
Who's Winning the Asian Auto Derby India is gaining a lap as its exports leap ahead, thanks to quality and engineering that Chinese carmakers can't match. |
The Motley Fool
March 31, 2010
Nathan Parmelee |
You Can't Afford to Ignore These Markets The recent U.S. equity rally is more bluster than substance, but international markets are the real deal. |
The Motley Fool
October 25, 2007
Brian Orelli |
Reddy for a Rollercoaster Ride In their quarterly results Dr. Reddy's Laboratories sees a dip in revenue from the loss of authorized generics. |
The Motley Fool
January 15, 2010
Tim Hanson |
This Is What a Real Growth Opportunity Looks Like Dr. Reddy's Laboratories is a small company with a wide market opportunity that stands to benefit from meaningful macroeconomic tailwinds. |
The Motley Fool
July 12, 2010
Jordan DiPietro |
Indian Stocks You Can Actually Buy Finding foreign stocks on U.S. indices can be difficult, so here's a start. |
The Motley Fool
November 21, 2007
Brian Orelli |
Black Friday Bargain Stock: Dr. Reddy's Laboratories Is Dr. Reddy's Laboratories a good value right now? Growth is slowing at the generic drugmaker, but is it enough to justify the drop in price? |
The Motley Fool
May 24, 2007
Bill Mann |
The Global Megatrend You Must Own If you never thought you could own a megatrend, now's your chance. As consumer economies in China, Mexico, India, Colombia, and so on grow at high rates, banks inevitably grow alongside them. That's where you can profit. |
AskMen.com
Scott Carter |
BRIC Investing: India In this four-part installment we look at India, which rides a wave of success from three primary sectors: information technology, pharmaceuticals and financial services. |
The Motley Fool
February 1, 2008
Kristin Graham |
Tata Motors Hits a Speed Bump Tata Motors growth may have decelerated this past quarter, but minor roadblocks won't stop the automaker's future. |
The Motley Fool
September 28, 2007
Nick Kapur |
Explosive Stocks in India India is attempting to build a foundation of sustainable yet powerful growth, and is doing it through a functional democratic process. Investors, with an annual growth rate of more than 7%, there are many Indian companies to keep an eye on. |
U.S. Banker
November 2009
Joseph Rosta |
India Needs More Banks India offers an expanding middle class and a seriously under-banked population. Western banks should be paying attention. |
The Motley Fool
July 10, 2007
Sham Gad |
HDFC Vaults Skyward The Indian bank is growing and poised to get even bigger. Investors, take note. |
The Motley Fool
October 30, 2006
Brian Lawler |
Reddy, Set, Go for Earnings Growth With margins tightening, generic drug maker Dr. Reddy's Laboratories finds an Rx for success. Investors, take note. |
The Motley Fool
October 11, 2011
Shubh Datta |
India, the New Auto Nucleus? Toyota will look to export cars from India by early next year. |
BusinessWeek
January 12, 2004
Manjeet Kripalani |
India: Big Pharma's New Promised Land? Drugmakers are heeding the siren call of its well-trained, cheap chemists. |
BusinessWeek
December 9, 2010
Siddharth Philip |
Driving in India: Cars, Corruption, Collisions In India, the roads are dangerous, the lawlessness is rampant, and the highways are getting more crowded by the minute. |
BusinessWeek
April 23, 2007
Gail Edmondson |
The Race To Build Really Cheap Cars The newest thing on four wheels is sturdy, inexpensive, and probably not made in the U.S. |
The Motley Fool
March 29, 2010
Ivan Martchev |
Pullbacks Are Buying Opportunities in Asia Here's why monetary tightening in China and India won't derail the boom. |
BusinessWeek
January 21, 2010
John Lee |
Don't Underestimate India's Consumers Western multinationals are often attracted to China's size, but they're bypassing Asia's true shopping powerhouse |
The Motley Fool
February 20, 2007
Todd Wenning |
Is It Time to Get Out? The Indian stock market has had an impressive run over the past five years. But are the good times coming to an end for Indian stocks? |
The Motley Fool
July 31, 2009
Brian Orelli |
Can Emerging Markets Save Pharma? Probably not until after they emerge. |
CIO
November 2, 2010
Gunjan Bagla |
Management in India: Three Things You Need to Know A management consultant advises CIOs on how best to work with Indian executives and their teams. |
The Motley Fool
July 20, 2006
Will Frankenhoff |
HDFC Banks on India's Growth Only investors with a long-term viewpoint -- and a cast-iron tolerance for volatility -- should take a long look at India's HDFC Bank, and see if they'd like to make a deposit for the future. |
The Motley Fool
February 9, 2010
Stephen Mauzy |
The Perils of Hot-Economy Investing The growth is nice, but the long-term returns often aren't. |
